1. RoentgenWC. "On a new kind of rays (preliminary communication)" Translation of a paper read before the Physikalische‐medicinischen Gesellschaft of Wurzburg on December 28, 1885. Br J Radiol1931;4:32. CrossRef

2. BergonieJ, TribondeauL. Interpretation of some results of radiotherapy and an attempt at a logical technique of treatment {Translation of original article in CR Acad Sci 143:983, 1906}. Radiat Res1959;11:587. CrossRef

3. PerezCA, BradyLW, Roti RotiJL. Overview. In: PerezCA, BradyLW(eds). Principles and Practice of Radiation Oncology. Philadelphia: Lippincott‐Raven Publishers; 1997: 1.

4. GallandRB, SpencerJ. The natural history of clinically established radiation enteritis. Lancet1985;1:1257. CrossRef

5. Smith‐BindmanR, MigliorettiDL, JohnsonE, et al.Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996–2010. JAMA2012;307:2400.

6. FazelR, KrumholzHM, WangY, et al.Exposure to low‐dose ionizing radiation from medical imaging procedures. N Engl J Med2009;361:849. CrossRef

7. ArenaV. Ionizing Radiation and Life. Saint Louis, MO: C. V. Mosby Company; 1971.

8. WithersHR, McBrideWH. Biological basis of radiation therapy. In: PerezCA, BradyLW(eds). Principles and Practice of Radiation Oncology. Philadelphia: Lippincott‐Raven Publishers; 1997: 79.

9. Hauer‐JensenM. Late radiation injury of the small intestine. Clinical, pathophysiologic and radiobiologic aspects. A review. Acta Oncol1990;29:401. CrossRef

10. ShadadAK, SullivanFJ, MartinJD, et al.Gastrointestinal radiation injury: symptoms, risk factors and mechanisms. World J Gastroenterol2013;19:185. CrossRef

11. CohnSM, SchloemannS, TessnerT, et al.Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxygenase‐1. J Clin Invest1997;99:1367. CrossRef

12. DuXX, DoerschukCM, OraziA, et al.A bone marrow stromal‐derived growth factor, interleukin 11, stimlates recovery of small intestinal mucosal cells after cytoablative therapy. Blood1994;83:33.

13. HouchenCW, GeorgeRJ, SturmoskiMA, et al.FGF‐2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol1999;276:G249.

14. HouchenCW, StensonWF, CohnSM. Disruption of cyclooxygenase‐1 gene results in an impaired response to radiation injury. Am J Physiol Gastrointest Liver Physiol2000;279:G858.

15. NetaR. Modulation of radiation damage by cytokines. Stem Cells1997;15(Suppl 2):87. CrossRef

16. Van der MeerenA, MouthonMA, GauglerMH, et al.Administration of recombinant human IL11 after supralethal radiation exposure promotes survival in mice: interactive effect with thrombopoietin. Radiat Res2002;157:642. CrossRef

17. BoothD, HaleyJD, BruskinAM, et al.Transforming growth factor‐B3 protects murine small intestinal crypt stem cells and animal survival after irradiation, possibly by reducing stem‐cell cycling. Int J Cancer2000;86:53. CrossRef

18. PottenCS, BoothD, HaleyJD. Pretreatment with transforming growth factor beta‐3 protects small intestinal stem cells against radiation damage in vivo. Br J Cancer1997;75:1454. CrossRef

19. WangY, MengA, LangH, et al.Activation of nuclear factor kappaB In vivo selectively protects the murine small intestine against ionizing radiation‐induced damage. Cancer Res2004;64:6240. CrossRef

20. BurdelyaLG, KrivokrysenkoVI, TallantTC, et al.An agonist of toll‐like receptor 5 has radioprotective activity in mouse and primate models. Science2008;320:226. CrossRef

21. SahaS, BhanjaP, LiuL, et al.TLR9 agonist protects mice from radiation‐induced gastrointestinal syndrome. PLoS ONE2012;7:e29357. CrossRef

22. CrawfordPA, GordonJI. Microbial regulation of intestinal radiosensitivity. Proc Natl Acad Sci U S A2005;102:13254. CrossRef

23. ChitapanaruxI, ChitapanaruxT, TraisathitP, et al.Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients. Radiat Oncol2010;5:31. CrossRef

24. DeliaP, SansottaG, DonatoV, et al.Use of probiotics for prevention of radiation‐induced diarrhea. Tumori2007;93 (Suppl):1.

25. FuccioL, GuidoA, EusebiLH, et al.Effects of probiotics for the prevention and treatment of radiation‐induced diarrhea. J Clin Gastroenterol2009;43:506. CrossRef

26. BrusoCE, ShewachDS, LawrenceTS. Fluorodeoxyuridine‐induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells. Int J Radiat Oncol Biol Phys1990;19:1411. CrossRef

27. HeimburgerDK, ShewachDS, LawrenceTS. The effect of fluorodeoxyuridine on sublethal damage repair in human colon cancer cells. Int J Radiat Oncol Biol Phys1991;21:983. CrossRef

28. HerskovicA, MartzK, al‐SarrafM, et al.Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med1992;326:1593. CrossRef

29. KrookJE, MoertelCG, GundersonLL, et al.Effective surgical adjuvant therapy for high‐risk rectal carcinoma. N Engl J Med1991;324:709. CrossRef

30. MoertelCG, FrytakS, HahnRG, et al.Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil: the Gastrointestinal Tumor Study Group. Cancer1981;48:1705. CrossRef

31. BrizelDM. Pharmacologic approaches to radiation protection. J Clin Oncol2007;25:4084. CrossRef

32. JahrausCD, BettenhausenD, MalikU, et al.Prevention of acute radiation‐induced proctosigmoiditis by balsalazide: a randomized, double‐blind, placebo controlled trial in prostate cancer patients. Int J Radiat Oncol Biol Phys2005;63:1483. CrossRef

33. FritzG, HenningerC, HuelsenbeckJ. Potential use of HMG‐CoA reductase inhibitors (statins) as radioprotective agents. Br Med Bull2011;97:17. CrossRef

34. SasakiH, HiraiK, YamamotoH, et al.HST‐1/FGF‐4 plays a critical role in crypt cell survival and facilitates epithelial cell restitution and proliferation. Oncogene2004;23:3681. CrossRef

35. KhanWB, ShuiC, NingS, et al.Enhancement of murine intestinal stem cell survival after irradiation by keratinocyte growth factor. Radiat Res1997;148:248. CrossRef

36. FarrellCL, BreadyJV, RexKL, et al.Keratinocyte growth factor protects mice from chemotherapy and radiation‐induced gastrointestinal injury and mortality. Cancer Res1998;58:933.

37. BeckPL, WongJF, LiY, et al.Chemotherapy‐ and radiotherapy‐induced intestinal damage is regulated by intestinal trefoil factor. Gastroenterology2004;126:796. CrossRef

38. LeQT, KimHE, SchneiderCJ, et al.Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo‐controlled study. J Clin Oncol2011;29:2808. CrossRef

39. LimayeSA, HaddadRI, CilliF, et al.Phase 1b, multicenter, single blinded, placebo‐controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer2013;119:4268. CrossRef

40. PosadasSJ, LargoC, MerinoJJ, et al.Growth hormone upregulates intestinal trefoil factor expression in the ileum of rats after gamma‐radiation. Exp Biol Med2011;236:205. CrossRef

41. CulyCR, SpencerCM. Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs2001;61:641. CrossRef

42. HartleyKO, GellD, SmithGC, et al.DNA‐dependent protein kinase catalytic subunit: a relative of phosphatidylinositol 3‐kinase and the ataxia telangiectasia gene product. Cell1995;82:849. CrossRef

43. Lees‐MillerSP, GodboutR, ChanDW, et al.Absence of p350 subunit of DNA‐activated protein kinase from a radiosensitive human cell line. Science1995;267:1183. CrossRef

44. PottenCS, BoothC. The role of radiation‐induced and spontaneous apoptosis in the homeostasis of the gastrointestinal epithelium: a brief review. Comp Biochem Physiol B Biochem Mol Biol1997;118:473. CrossRef

45. PottenCS, WilsonJW, BoothC. Regulation and significance of apoptosis in the stem cells of the gastrointestinal epithelium. Stem Cells1997;15:82. CrossRef

46. PottenCS, LoefflerM. A comprehensive model of the crypts of the small intestine of the mouse provide insight into the mechanisms of cell migration and the proliferation hierchy. J Theor Biol1987;127:381. CrossRef

47. WilsonJW, PritchardDM, HickmanJA, et al.Radiation‐induced p53 and p21WAF‐1/CIP1 expression in the murine intestinal epithelium: apoptosis and cell cycle arrest. Am J Pathol1998;153:899. CrossRef

48. EwenME, MillerSJ. p53 and translational control. Biochim Biophys Acta1996;1242:181.

49. LaneDP. p53, guardian of the genome. Nature1992;358:15. CrossRef

50. LevineAJ. p53, the cellular gatekeeper for growth and division. Cell1997;88:323. CrossRef

51. El‐DieryWS, TokinoT, VelculescuVE, et al.WAFI, a potential mediator of p53 tumor supression. Cell1993;75:817. CrossRef

52. MiyashitaT, ReedJC. Tumor suppressor p53 in a direct transcriptional activator of the human bax gene. Cell1995;80:293. CrossRef

53. WuX, BayleJH, OlsenD, et al.The p53‐mdm‐2 autoregulatoy feedback loop. Genes Dev1993;7:1125.

54. KuerbitzS, PlunketB, WalshW, et al.Wild‐type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A1992;89:7491. CrossRef

55. MerrittAJ, PottenCS, KempCJ, et al.The role of p53 in spontaneous and radiation‐induced apoptosis in the gastrointestinal tract of normal and p53‐deficient mice. Cancer Res1994;54:614.

56. ZhanQ, CarrierF, FornaceA. Induction of cellular p53 activity by DNA‐damaging agents and growth arrest. Mol Cell Biol1993;13:4242. CrossRef

57. ParisF, FuksZ, KangA, et al.Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science2001;293:293. CrossRef

58. RotoloJA, KolesnickR, FuksZ. Timing of lethality from gastrointestinal syndrome in mice revisited. Int J Radiat Oncol Biol Phys2009;73:6. CrossRef

59. RotoloJA, MajJG, FeldmanR, et al.Bax and Bak do not exhibit functional redundancy in mediating radiation‐induced endothelial apoptosis in the intestinal mucosa. Int J Radiat Oncol Biol Phys2008;70:804. CrossRef

60. StancevicB, KolesnickR. Ceramide‐rich platforms in transmembrane signaling. FEBS Lett2010;584:1728. CrossRef

61. RotoloJ, StancevicB, ZhangJ, et al.Anti‐ceramide antibody prevents the radiation gastrointestinal syndrome in mice. J Clin Invest2012;122:1786. CrossRef

62. LeibowitzBJ, QiuW, LiuH, et al.Uncoupling p53 functions in radiation‐induced intestinal damage via PUMA and p21. Mol Cancer Res2011;9:616. CrossRef

63. YuH, ShenH, YuanY, et al.Deletion of Puma protects hematopoietic stem cells and confers long‐term survival in response to high‐dose gamma‐irradiation. Blood2010;115:3472. CrossRef

64. YuJ, ZhangL. PUMA, a potent killer with or without p53. Oncogene2008;27(Suppl 1):S71. CrossRef

65. QiuW, Carson‐WalterEB, LiuH, et al.PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell2008;2:576. CrossRef

66. QiuW, LeibowitzB, ZhangL, et al.Growth factors protect intestinal stem cells from radiation‐induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene2010;29:1622. CrossRef

67. MustataG, LiM, ZevolaN, et al.Development of small‐molecule PUMA inhibitors for mitigating radiation‐induced cell death. Curr Top Med Chem2011;11:281. CrossRef

68. BjerknesM, ChengH. Clonal analysis of mouse intestinal epithelial progenitors. Gastroenterology1999;116:7. CrossRef

69. BjerknesM, ChengH. Gastrointestinal stem cells. II. Intestinal stem cells. Am J Physiol Gastrointest Liver Physiol2005;289:G381. CrossRef

70. PottenCS, BoothC, PritchardDM. The intestinal epithelial stem cell: the mucosal governor. Int J Exp Pathol1997;78:219. CrossRef

71. BarkerN, van EsJH, JaksV, et al.Very long‐term self‐renewal of small intestine, colon, and hair follicles from cycling Lgr5+ve stem cells. Cold Spring Harb Symp Quant Biol2008;73:351. CrossRef

72. BarkerN, van EsJH, KuipersJ, et al.Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature2007;449:1003. CrossRef

73. SangiorgiE, CapecchiMR. Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet2008;40:915. CrossRef

74. van EsJH, SatoT, van de WeteringM, et al.Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nat Cell Biol2012;14:1099. CrossRef

75. MerrittAJ, AllenTD, PottenCS, et al.Apoptosis in small intestinal epithelial from p53‐null mice: evidence for a delayed, p53‐independent G2/M‐associated cell death after gamma‐irradiation. Oncogene1997;14:2759. CrossRef

76. FajardoLF. Radiation‐induced pathology of the alimentary tract. In: WhiteheadR(ed). Gastrointestinal and Oesophageal Patholgoy, 2nd edn. New York: Churchill Livingstone; 1995: 957.

77. ChenKY, WithersHR. Survival characteristics of stem cells of gastric mucosa in C 3 H mice subjected to localized gamma irradiation. Int J Radiat Biol Relat Stud Phys Chem Med1972;21:521. CrossRef

78. PottenCS. A comprehensive study of the radiobiological response of murine (BDF1) small intestine. Int J Radiat Biol1990;58:925. CrossRef

79. TrierJS, BrowningTH. Morphologic response of the mucosa of human small intestine to x‐ray exposure. J Clin Invest1966;45:194. CrossRef

80. VatistasS, HornseyS. Radiation‐induced protein loss into the gastrointestinal tract. Br J Radiol1966;39:547. CrossRef

81. WithersHR. Regeneration of intestinal mucosa after irradiation. Cancer1971;28:75. CrossRef

82. WhiteDC. An Atlas of Radiation Histopathology. Oak Ridge, TN: Technical Information Center, Office of Public Affairs, US Energy Research and Development Administration; 1975: 75.

83. McDonaldGB, HindsMS, FisherLD, et al.Veno‐occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med1993;118:255. CrossRef

84. ShulmanHM, FisherLB, SchochHG, et al.Veno‐occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology1994;19:1171. CrossRef

85. StrasserSI, McDonaldGB. Hepatobilliary complications of Hematopoietic Cell Transplantation. In: SchiffER, SorrellMF, MaddreyWC(eds). Schiff's Diseases of the Liver, vol. 2, 8th edn. Philadelphia: Lippincott‐Raven; 1993: 1617.

86. ShulmanHM, GownAM, NugentDJ. Hepatic veno‐occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol1987;127:549.

87. EpsteinRB, MinKW, AndersonSL, et al.A canine model for hepatic venoocclusive disease. Transplantation1992;54:12. CrossRef

88. GeraciJP, MarianoMS, JacksonKL. Radiation hepatology of the rat: microvascular fibrosis and enhancement of liver dysfunction by diet and drugs. Radiat Res1992;129:322. CrossRef

89. ShulmanHM, LukK, DeegHJ, et al.Induction of hepatic veno‐occlusive disease in dogs. [erratum appears in Am J Pathol 1987 Apr;127(1):following 198]. Am J Pathol1987;126:114.

90. BerthrongM. Pathologic changes secondary to radiation. World J Surg1986;10:155. CrossRef

91. BerthrongM, FajardoLF. Radiation injury in surgical pathology. Part II. Alimentary tract. Am J Surg Pathol1981;5:153. CrossRef

92. CastroEB, RosenPP, QuanSH. Carcinoma of large intestine in patients irradiated for carcinoma of cervix and uterus. Cancer1973;31:45. CrossRef

93. DenmanDL, KirchnerFR, OsborneJW. Induction of colonic adenocarcinoma in the rat by X‐irradiation. Cancer Res1978;38:1899.

94. GreenwaldR, BarkinJS, HensleyGT, et al.Cancer of the colon as a late sequel of pelvic irradiation. Am J Gastroenterol1978;69:196.

95. DollR, SmithPG. The long‐term effects of x irradiation in patients treated for metropathia haemorrhagica. Br J Radiol1968;41:362. CrossRef

96. KatoH, SchullWJ. Studies of the mortality of A‐bomb survivors. 7. Mortality, 1950–1978: Part I. Cancer mortality. Radiat Res1982;90:395. CrossRef

97. SandlerRS, SandlerDP. Radiation‐induced cancers of the colon and rectum: assessing the risk. Gastroenterology1983;84:51.

98. SeamanWB, AckermanLV. The effect of radiation on the esophagus. Radiology1957;68:534. CrossRef

99. NovakJM, CollinsJT, DonowitzM, et al.Effects of radiation on the human gastrointestinal tract. J Clin Gastroenterol1979;1:9. CrossRef

100. VanagunasA, JacobP, OlingerE. Radiation‐induced esophageal injury: a spectrum from esophagitis to cancer. Am J Gastroenterol1990;85:808.

101. CoiaLR, MyersonRJ, TepperJE. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys1995;31:1213. CrossRef

102. PepekJM, WillettCG, WuQJ, et al.Intensity‐modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. Int J Radiat Oncol Biol Phys2010;78:1413. CrossRef

103. SassoFS, SassoG, MarsigliaHR, et al.Pharmacological and dietary prophylaxis and treatment of acute actinic esophagitis during mediastinal radiotherapy. Dig Dis Sci2001;46:746. CrossRef

104. ChowhanNM. Injurious effects of radiation on the esophagus. Am J Gastroenterol1990;85:115.

105. SalvoN, DobleB, KhanL, et al.Prophylaxis of radiation‐induced nausea and vomiting using 5‐hydroxytryptamine‐3 serotonin receptor antagonists: a systematic review of randomized trials. Int J Radiat Oncol Biol Phys2012;82:408. CrossRef

106. NgTM, SpencerGM, SargeantIR, et al.Management of strictures after radiotherapy for esophageal cancer. Gastrointest Endosc1996;43:584. CrossRef

107. KinsmanKJ, DeGregorioBT, KatonRM, et al.Prior radiation and chemotherapy increase the risk of life‐threatening complications after insertion of metallic stents for esophagogastric malignancy.Gastrointest Endosc1996;43:196. CrossRef

108. KellumJM, JaffeBM, CalhounTR, et al.Gastric complications after radiotherapy for Hodgkin's disease and other lymphomas. Am J Surg1977;134:314. CrossRef

109. FeiringW, JampolML. Perforation of a gastric ulcer following intensive radiation therapy. N Engl J Med1950;242:751. CrossRef

110. MillerAR, MartensonJA, NelsonH, et al.The incidence and clinical consequences of treatment‐related bowel injury. Int J Radiat Oncol Biol Phys1999;43:817. CrossRef

111. PerezCA, GrigsbyPW, LockettMA, et al.Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys1999;44:855. CrossRef

112. TarpilaS. Morphological and functional response of human small intestine to ionizing radiation. Scand J Gastroenterol1971;6(Suppl 12):1. CrossRef

113. MannWJ. Surgical management of radiation enteropathy. Surg Clin North Am1991;71:977.

114. SherME, BauerJ. Radiation‐induced enteropathy. Am J Gastroenterol1990;85:121.

115. DonaldsonSS, JundtS, RicourC, et al.Radiation enteritis in children. A retrospective review, clinicopathologic correlation, and dietary management. Cancer1975;35:1167. CrossRef

116. DeCosseJJ, RhodesRS, WentzWB, et al.The natural history and management of radiation induced injury of the gastrointestinal tract. Ann Surg1969;170:369. CrossRef

117. SchierJ, SymmondsRE, DahlinDC. Cinicopathologic aspects of radiation enteritis. Surg Gynecol Obstet1964;119:1019.

118. WellwoodJM, JacksonBT. The intestinal complications of radiotherapy. Br J Surg1973;60:814. CrossRef

119. DenckerH, HolmdahlKH, LunderquistA, et al.Mesenteric angiography in patients with radiation injury of the bowel after pelvis irradiation. Am J Roentgenol Radium Ther Nucl Med1972;114:476. CrossRef

120. LeeDW, PoonAO, ChanAC. Diagnosis of small bowel radiation enteritis by capsule endoscopy. Hong Kong Med J2004;10:419.

121. SpadaC, SperaG, RiccioniM, et al.A novel diagnostic tool for detecting functional patency of the small bowel: the Given patency capsule. Endoscopy2005;37:793. CrossRef

122. HarlingH, BalslevI. Long‐term prognosis of patients with severe radiation enteritis. Am J Surg1988;155:517. CrossRef

123. DanielssonA, NyhlinH, PerssonH, et al.Chronic diarrhoea after radiotherapy for gynaecological cancer: occurrence and aetiology. Gut1991;32:1180. CrossRef

124. YeohE, HorowitzM, RussoA, et al.Effect of pelvic irradiation on gastrointestinal function: a prospective longitudinal study. Am J Med1993;95:397. CrossRef

125. BurnettAF, CoeFL, KlementV, et al.The use of a pelvic displacement prosthesis to exclude the small intestine from the radiation field following radical hysterectomy. Gynecol Oncol2000;79:438. CrossRef

126. RodierJF, JanserJC, DelahayeJF, et al.Use of polyglactin 910 mesh (Vicryl) in pelvic oncologic surgery. Adv Ther1992;9:233.

127. SezeurA, MartellaL, AbbouC, et al.Small intestine protection from radiation by means of a removable adapted prosthesis. Am J Surg1999;178:22; discussion 5. CrossRef

128. ParkW, HuhSJ, LeeJE, et al.Variation of small bowel sparing with small bowel displacement system according to the physiological status of the bladder during radiotherapy for cervical cancer. Gynecol Oncol2005;99:645. CrossRef

129. DeitelM, ToTB. Major intestinal complications of radiotherapy. Management and nutrition. Arch Surg1987;122:1421. CrossRef

130. GallandRB, SpencerJ. Spontaneous postoperative perforation of previously asymptomatic irradiated bowel. Br J Surg1985;72:285. CrossRef

131. WellwoodJM, JacksonBT, BatesTD. Breakdown of small‐bowel anastomoses after pelvic radiotherapy. Ann R Coll Surg Engl1974;54:306.

132. YeohEK, HorowitzM, RussoA, et al.Gastrointestinal function in chronic radiation enteritis–effects of loperamide‐N‐oxide. Gut1993;34:476. CrossRef

133. KilicD, EgehanI, OzenirlerS, et al.Double‐blinded, randomized, placebo‐controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother Oncol2000;57:125. CrossRef

134. ResbeutM, MarteauP, CowenD, et al.A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol1997;44:59. CrossRef

135. KozelskyTF, MeyersGE, SloanJA, et al.Phase III double‐blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol2003;21:1669. CrossRef

136. Vidal‐CasariegoA, Calleja‐FernandezA, de Urbina‐GonzalezJJ, et al.Efficacy of glutamine in the prevention of acute radiation enteritis: a randomized controlled trial. JPEN J Parenter Enteral Nutr2014;38:205. CrossRef

137. McArdleAH. Protection from radiation injury by elemental diet: does added glutamine change the effect?Gut1994;35(1 Suppl):S60. CrossRef

138. SilvainC, BessonI, IngrandP, et al.Long‐term outcome of severe radiation enteritis treated by total parenteral nutrition. Dig Dis Sci1992;37:1065. CrossRef

139. LoiudiceTA, LangJA. Treatment of radiation enteritis: a comparison study. Am J Gastroenterol1983;78:481.

140. VargheseSKJ. Lack of improvement in fistulizing radiation enteritis after infliximab therapy: a case report. Am J Gastroenterol2000;95:2613. CrossRef

141. RegimbeauJ, PanisY, GouziJ, et al.Operative and long term results after surgery for chronic radiation enteritis. Am J Surg2001;182:237. CrossRef

142. van HalterenHK, GortzakE, TaalBG, et al.Surgical intervention for complications caused by late radiation damage of the small bowel: a retrospective analysis. Eur J Surg Oncol1993;19:336.

143. SchmitzRL, ChaoJH, BartolomeJS. Intestinal injuries incidental to irradiation of carcinoma of the cervix of the uterus. Surg Gynecol Obstet1974;138:29.

144. FriedmanM(ed). Calculated risks of radiation injury of normal tissue in the treatment of cancer of the testis. American Cancer Society: Proceedings of the Second National Cancer Conference; 1952; New York: National Cancer Institute USPHS Federal Science Agency.

145. BabbRR. Radiation proctitis: a review. Am J Gastroenterol1996;91:1309.

146. HanBH, DemelKC, WallnerK, et al.Patient reported complications after prostate brachytherapy. J Urol2001;166:953. CrossRef

147. RoswitB, MalskySJ, ReidCB. Severe radiation injuries of the stomach, small intestine, colon and rectum. Am J Roentgenol Radium Ther Nucl Med1972;114:460. CrossRef

148. SchultheissTE, LeeWR, HuntMA, et al.Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys1997;37:3. CrossRef

149. HovdenakN, FajardoLF, Hauer‐JensenM. Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys2000;48:1111. CrossRef

150. GilinskyNH, BurnsDG, BarbezatGO, et al.The natural history of radiation‐induced proctosigmoiditis: an analysis of 88 patients. Q J Med1983;52:40.

151. KochharR, PatelF, DharA, et al.Radiation‐induced proctosigmoiditis. Prospective, randomized, double‐blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci1991;36:103. CrossRef

152. HenrikssonR, FranzenL, LittbrandB. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. J Clin Oncol1992;10:969.

153. SasaiT, HiraishiH, SuzukiY, et al.Treatment of chronic post‐radiation proctitis with oral administration of sucralfate. Am J Gastroenterol1998;93:1593. CrossRef

154. KneeboneA, MameghanH, BolinT, et al.Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: a double‐blind, randomized trial. Int J Radiat Oncol Biol Phys2004;60:1088. CrossRef

155. O'BrienPC, FranklinCI, DearKB, et al.A phase III double‐blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis. Radiother Oncol1997;45:117. CrossRef

156. PintoA, FidalgoP, CravoM, et al.Short chain fatty acids are effective in short‐term treatment of chronic radiation proctitis: randomized, double‐blind, controlled trial. Dis Colon Rectum1999;42:788; discussion 95. CrossRef

157. VerniaP, FracassoPL, CasaleV, et al.Topical butyrate for acute radiation proctitis: randomised, crossover trial. Lancet2000;356:1232. CrossRef

158. KennedyM, BruningaK, MutluEA, et al.Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. Am J Gastroenterol2001;96:1080. CrossRef

159. PikarskyAJ, BelinB, EfronJ, et al.Complications following formalin installation in the treatment of radiation induced proctitis. Int J Colorectal Dis2000;15:96. CrossRef

160. CounterSF, FroeseDP, HartMJ. Prospective evaluation of formalin therapy for radiation proctitis. Am J Surg1999;177:396. CrossRef

161. BemJ, BemS, SinghA. Use of hyperbaric oxygen chamber in the management of radiation‐related complications of the anorectal region: report of two cases and review of the literature. Dis Colon Rectum2000;43:1435. CrossRef

162. CharneauJ, BouachourG, PersonB, et al.Severe hemorrhagic radiation proctitis advancing to gradual cessation with hyperbaric oxygen. Dig Dis Sci1991;36:373. CrossRef

163. FantinAC, BinekJ, SuterWR, et al.Argon beam coagulation for treatment of symptomatic radiation‐induced proctitis. Gastrointest Endosc1999;49:515. CrossRef

164. KaassisM, ObertiE, BurtinP, et al.Argon plasma coagulation for the treatment of hemorrhagic radiation proctitis. Endoscopy2000;32:673. CrossRef

165. RolachonA, PapillonE, FournetJ. [Is argon plasma coagulation an efficient treatment for digestive system vascular malformation and radiation proctitis?]. Gastroenterol Clin Biol2000;24:1205.

166. TamW, MooreJ, SchoemanM. Treatment of radiation proctitis with argon plasma coagulation. Endoscopy2000;32:667. CrossRef

167. CanardJM, VedrenneB, BorsG, et al.[Long term results of treatment of hemorrhagic radiation proctitis by argon plasma coagulation]. Gastroenterol Clin Biol2003;27:455.

168. Chruscielewska‐KiliszekMR, RegulaJ, PolkowskiM, et al.Sucralfate or placebo following argon plasma coagulation for chronic radiation proctitis: a randomized double blind trial. Colorectal Dis2013;15:e48. CrossRef

169. HouJK, AbudayyehS, ShaibY. Treatment of chronic radiation proctitis with cryoablation. Gastrointest Endosc2011;73:383. CrossRef

170. CraigheadP, Shea‐BudgellMA, NationJ, et al.Hyperbaric oxygen therapy for late radiation tissue injury in gynecologic malignancies. Curr Oncol2011;18:220. CrossRef

171. MarksG, MohiuddenM. The surgical management of the radiation‐injured intestine. Surg Clin North Am1983;63:81.

172. CromheeckeM, KoningsAW, SzaboBG, et al.Liver tissue tolerance for irradiation: experimental and clinical investigations. Hepatogastroenterology2000;47:1732.

173. IngoldDK, ReedGB, KaplanHS. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med1965;93:200.

174. ReedGB, CoxAJ. The human liver after radiation injury. A form of veno‐occlusive disease. Am J Pathol1966;48:597.

175. BarnardJA, MarshallGS, NeblettWW, et al.Noncirrhotic portal fibrosis after Wilms' tumor therapy. Gastroenterology1986;90:1054.

176. WhartonJT, DelclosL, GallagerS, et al.Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med1973;117:73. CrossRef

177. MornexF, GerardF, RamuzO, et al.Effets tardifs des radiations sur le foie. Cancer Radiother1997;1:753. CrossRef

178. YamasakiSA, MarnCS, FrancisIR, et al.High‐dose localized radiation therapy for treatment of hepatic malignant tumors: CT findings and their relation to radiation hepatitis. AJR Am J Roentgenol1995;165:79. CrossRef

179. AhmadiT, ItaiY, OnayaH, et al.CT evaluation of hepatic injury following proton beam irradiation: appearance, enhancement, and 3D size reduction pattern. J Comput Assist Tomogr1999;23:655. CrossRef

180. McDonaldGB, SharmaP, MatthewsDE, et al.Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology1984;4:116. CrossRef

181. McDonaldGB, SharmaP, MatthewsDE, et al.The clinical course of 53 patients with venocclusive disease of the liver after marrow transplantation. Transplantation1985;39:603. CrossRef

182. HaddadE, Le BourgeoisJP, KuentzM, et al.Liver complications in lymphomas treated with a combination of chemotherapy and radiotherapy: preliminary results. Int J Radiat Oncol Biol Phys1983;9:1313. CrossRef

183. McCrackenJD, WeatherallTJ, OishiN, et al.Adjuvant intrahepatic chemotherapy with mitomycin and 5‐FU combined with hepatic irradiation in high‐risk patients with carcinoma of the colon: a Southwest Oncology Group phase II pilot study. Cancer Treat Rep1985;69:129.